Patient with Fistulizing Crohn's Disease with Nonresponse to Infliximab Subsequently Responds to Infliximab After Short-term Addition of Tacrolimus

Inflamm Bowel Dis. 2021 Jan 19;27(2):e20-e22. doi: 10.1093/ibd/izaa260.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal* / therapeutic use
  • Crohn Disease* / complications
  • Crohn Disease* / drug therapy
  • Gastrointestinal Agents* / therapeutic use
  • Humans
  • Infliximab / therapeutic use
  • Intestinal Fistula / etiology
  • Tacrolimus* / therapeutic use
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Infliximab
  • Tacrolimus